相关实验视频

Updated: Jun 23, 2025

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

[抗NMDA受体脑炎的病例报告与精神障碍的表现]

M S Sheyfer^1,2, E G Paloyko¹, A J Gayduk²

¹Samara Regional Clinical Psychiatric Hospital, Samara, Russia.

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

|June 17, 2024

概括

抗NMDA受体脑炎是一种罕见的自身免疫性疾病,表现为精神症状和神经缺陷. 早期诊断和治疗,包括免疫疗法和解决相关的卵巢瘤,导致积极的结果.

科学领域:

神经学神经学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

2007年首次描述的抗NMDA受体脑炎是一种罕见的自身免疫神经系统疾病.
它经常表现为严重的精神表现和白内障,导致由于危及生命的呼吸和血液动力学损害导致重症监护室入院.
尽管这种疾病具有显著的临床影响,但其研究不足.

研究的目的:

为了提出对抗NMDA受体脑炎的临床观察.
突出诊断标准和治疗策略.
强调认识到卵巢瘤作为一种常见的并发症的重要性.

主要方法:

诊断依赖于检测血清和脑脊液中对谷氨酸NMDA受体NR1和NR2子单元的自身抗体.
治疗包括免疫疗法,包括葡萄糖皮质激素,静脉注射免疫球蛋白,血酶,单克隆抗体,在严重情况下可能是细胞静止剂.
对卵巢瘤的查和早期切除至关重要,特别是在女性中.

主要成果:

该研究观察了抗NMDA受体脑炎的临床表现和管理.
有效的治疗策略涉及免疫疗法和解决潜在原因的组合.
妇女的卵巢瘤具有很高的并发病率 (高达60%).

结论:

抗NMDA受体脑炎需要及时诊断和全面治疗.
及时干预,包括免疫疗法和卵巢瘤的管理,显著改善患者的预后.
需要进一步的研究才能充分理解和管理这种罕见但严重的疾病.

关键词:

抗NMDA-R脑炎的治疗方法案例报告案例报告这是临床表现的临床表现.早期诊断早期诊断早期诊断精神障碍精神障碍精神障碍

更多相关视频

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.